Depakote® (divalproex sodium) delayed-release tablets, for oral use

Eligible patients could pay as little as $5/month*

Depakote Savings Card offer only good with the Depakote brand.

Depakote Savings Card

GET YOUR DEPAKOTE SAVINGS CARD
Eligible patients can save instantly*

Nearly 7 out of 10 patients

PAY AS LITTLE AS $5/MONTH*

Join the nearly 7 out of 10 patients that pay the same or less than the generic when they use the Depakote Savings Card1

Depakote ER dispense as written

GET WHAT YOU ARE PRESCRIBED

By having your doctor add “Dispense as Written” to your prescription, your pharmacist will fill your prescription with the brand specified.

Text to save

TEXT TO SAVE

  • Download your Depakote Savings Card now Text “SAVE” to 58752
  • Or download here
Pharmacy bag

HELP SAVE TRIPS TO THE PHARMACY

Converting a 30-day to a 90-day prescription may save trips to the pharmacy. Ask your doctor.

QUESTIONS ABOUT DEPAKOTE?

We may have already answered them...

GET ANSWERS
IS DEPAKOTE RIGHT FOR YOU?

Learn more today.

LEARN MORE

*Up to $100/month savings for eligible patients.

Or your state’s legal language.

By texting “SAVE” from your phone to the above number, you confirm that you are 18 years of age or older and consent to receive recurring text messages from AbbVie, including service updates, medication reminders, and marketing messages. Message and data rates may apply. Your consent is not a condition of receiving goods or services. You can reply HELP for help or text STOP to unsubscribe at any time.

ELIGIBILITY

Available to patients with commercial prescription insurance coverage for Depakote who meet eligibility criteria. Copay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the Depakote Savings Card and patient must call OPUS Health at 800.364.4767 to stop participation. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from the Depakote Savings Card from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. Please see full Terms and Conditions.

TERMS AND CONDITIONS

Pharmacist Instructions

  • Submit the copay card authorized for all commercially insured patients by the patient’s primary insurance as a secondary transaction to OPUS Health.
  • When you use this card, you are confirming that you have not submitted and will not submit a claim for this prescription for reimbursement under any federal, state, or government-funded healthcare program, such as Medicare (including Part D), Medicare Advantage, Medicaid, Medigap, Veterans Affairs, the Department of Defense, or TRICARE.
  • Pharmacists with questions please call OPUS Health at 800.364.4767.

WHAT IS DEPAKOTE USED FOR?2-4

DEPAKOTE comes in different dosage forms for oral use. DEPAKOTE® (divalproex sodium) delayed-release tablets and DEPAKOTE® ER (divalproex sodium) extended-release tablets are prescription medicines used:

  • alone or with other medicines to treat:
    • complex partial seizures in adults and children 10 years of age and older
    • simple and complex absence seizures
  • with other medications to treat:
    • patients with multiple seizure types that include absence seizures

DEPAKOTE ER and DEPAKOTE are also used to prevent migraine headaches.

DEPAKOTE ER is also used to treat acute manic or mixed episodes associated with bipolar disorder with or without psychotic features.

DEPAKOTE is also used to treat manic episodes associated with bipolar disorder.

DEPAKOTE® Sprinkle Capsules (divalproex sodium), delayed release capsules for oral use, is a prescription medicine used:

  • alone or with other medicines to treat:
    • complex partial seizures in adults and children 10 years of age and older
    • simple and complex absence seizures
  • with other medications to treat:
    • patients with multiple seizure types that include absence seizures

IMPORTANT SAFETY INFORMATION2-4

The most important information about DEPAKOTE is:

Do not stop taking DEPAKOTE without first talking to your healthcare provider. Stopping DEPAKOTE suddenly can cause serious problems. Stopping a seizure medicine suddenly in a patient who has epilepsy can cause seizures that will not stop (status epilepticus).

DEPAKOTE can cause serious side effects, including:

  • Serious liver damage that can cause death, especially in children younger than 2 years old and patients with mitochondrial disorders. The risk of getting this serious liver damage is more likely to happen within the first 6 months of treatment. In some cases, liver damage may continue even though the medicine is stopped. Your healthcare provider will do blood tests to check your liver before and during treatment with DEPAKOTE. Call your healthcare provider right away if you get any of the following symptoms: feeling very weak, tired, or uncomfortable (malaise); swelling of your face; not feeling hungry; nausea or vomiting that does not go away; diarrhea; pain on the right side of your stomach (abdomen); dark urine; yellowing of your skin or the whites of your eyes; or loss of seizure control in people with epilepsy.
  • DEPAKOTE may harm your unborn baby. If you take DEPAKOTE during pregnancy for any medical condition, your baby is at risk for serious birth defects that affect the brain and spinal cord (such as spina bifida or neural tube defects). These defects can begin in the first month, even before you know you are pregnant. Other birth defects that affect the structures of the heart, head, arms, legs, and the opening where the urine comes out (urethra) on the bottom of the penis can also happen. Decreased hearing or hearing loss can also happen. Birth defects may occur even in children born to women who are not taking any medicines and do not have other risk factors. Taking folic acid supplements before getting pregnant and during early pregnancy can lower the chance of having a baby with a neural tube defect. If you take DEPAKOTE during pregnancy for any medical condition, your child is at risk for having a lower IQ and may be at risk for developing autism or attention-deficit/hyperactivity disorder. There may be other medicines to treat your condition that have a lower chance of causing birth defects, decreased IQ, or other disorders in your child. Women who are pregnant must not take DEPAKOTE to prevent migraine headaches. All women of childbearing age (including girls from the start of puberty) should talk to their healthcare provider about using other possible treatments instead of DEPAKOTE. If the decision is made to use DEPAKOTE, you should use effective birth control (contraception). Tell your healthcare provider right away if you become pregnant while taking DEPAKOTE. You and your healthcare provider should decide if you will continue to take DEPAKOTE while you are pregnant. Pregnancy Registry: If you become pregnant while taking DEPAKOTE, talk to your healthcare provider about registering with the North American Antiepileptic Drug (NAAED) Pregnancy Registry. You can enroll in this registry by calling toll-free 1-888-233-2334 or by visiting the website, www.aedpregnancyregistry.org. The purpose of this registry is to collect information about the safety of antiepileptic drugs during pregnancy.
  • Swelling (inflammation) and bleeding (hemorrhaging) of your pancreas that can cause death. Call your healthcare provider right away if you have any of these symptoms: severe stomach pain that you may also feel in your back, nausea or vomiting that does not go away, or not feeling hungry.
  • Like other antiepileptic drugs, DEPAKOTE may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call a healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry you: thoughts about suicide or dying; attempts to commit suicide; new or worse depression; new or worse anxiety; feeling agitated or restless; panic attacks; trouble sleeping (insomnia); new or worse irritability; acting aggressive; being angry or violent; acting on dangerous impulses; an extreme increase in activity and talking (mania); or other unusual changes in behavior or mood. How can I watch for early symptoms of suicidal thoughts and actions? Pay attention to any changes, especially sudden changes in mood, behaviors, thoughts, or feelings. Keep all follow-up visits with your healthcare provider as scheduled. Call your healthcare provider between visits as needed, especially if you are worried about symptoms.

Do not take DEPAKOTE if you:

  • have liver problems
  • have or think you have a genetic liver problem caused by a mitochondrial disorder such as Alpers-Huttenlocher syndrome
  • are allergic to divalproex sodium, valproic acid, sodium valproate, or any of the ingredients in DEPAKOTE
  • have a genetic problem called a urea cycle disorder
  • are taking it to prevent migraine headaches and are either pregnant or may become pregnant because you are not using effective birth control (contraception)

Before taking DEPAKOTE, tell your healthcare provider about all your medical conditions, including if you:

  • have or have had liver problems
  • have or think you have a genetic liver problem caused by a mitochondrial disorder such as Alpers-Huttenlocher syndrome
  • drink alcohol
  • have or have had depression, suicidal thoughts or behavior, unusual changes in mood, or thoughts about self-harm
  • are male and plan to father a child. DEPAKOTE may cause fertility problems, which may affect your ability to father a child. Talk to your healthcare provider if this is a problem for you.
  • are pregnant or may become pregnant. DEPAKOTE may harm your unborn baby. See “DEPAKOTE may harm your unborn baby” above for more information.
  • are breastfeeding. DEPAKOTE can pass into breast milk and may harm your baby. Talk to your healthcare provider about the best way to feed your baby if you take DEPAKOTE.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

DEPAKOTE may affect the way other medicines work, and other medicines may affect how DEPAKOTE works. Using DEPAKOTE with other medicines can cause serious side effects. Do not start or stop other medicines without talking to your healthcare provider.

Especially tell your healthcare provider if you take:

  • medicines that can affect how the liver breaks down other medicines (such as phenytoin, carbamazepine, felbamate, phenobarbital, primidone, or rifampin)
  • aspirin, carbapenem antibiotics, or estrogen-containing hormonal contraceptives
  • methotrexate
  • topiramate
  • cannabidiol

You can ask your healthcare provider or pharmacist for a list of these medicines if you are not sure.

DEPAKOTE can cause other serious side effects, including:

  • Bleeding problems: Problems may include bruising or red or purple spots on your skin, bleeding from your mouth or nose, coughing up blood or blood clots, vomiting blood or vomit that looks like coffee grounds, blood in your stools or black stools (looks like tar), or pain and swelling in your joints.
  • Increased ammonia levels in your blood: High ammonia levels can seriously affect your mental activities, slow your alertness, make you feel tired, or cause vomiting (encephalopathy). This has happened when DEPAKOTE is taken alone or with a medicine called topiramate. Call your healthcare provider if you have any of these symptoms.
  • Low body temperature (hypothermia): A drop in your body temperature to less than 95º F can happen during treatment with DEPAKOTE. Call your healthcare provider if you have any of the following symptoms: feeling tired, confusion, memory loss, drowsiness, coma, or shivering.
  • Severe multiorgan reactions: Treatment with DEPAKOTE may cause severe multiorgan reactions that can be life-threatening or may lead to death. Stop taking DEPAKOTE and contact your healthcare provider or get medical help right away if you develop any of these symptoms of a severe skin reaction: fever; skin rash; hives; sores in your mouth; blistering and peeling of your skin; swelling of your lymph nodes; swelling of your face, eyes, lips, tongue, or throat; or trouble swallowing or breathing.
  • Drowsiness or sleepiness in the elderly: This extreme drowsiness may cause you to eat or drink less than you normally would. Tell your healthcare provider if you are not able to eat or drink as you normally do. Your healthcare provider may start you at a lower dose of DEPAKOTE.
  • Medicine residue in your stool: Tell your healthcare provider if you have or think you may have medicine residue in your stool.

Common side effects of DEPAKOTE include: headache, weakness, sleepiness, dizziness, tremors, difficulty walking or problems with coordination, ringing in your ears, blurred vision, double vision, unusual eye movement, hair loss (alopecia), swelling of your arms or legs, loss of appetite, weight loss, increased appetite, weight gain, nausea/vomiting, stomach pain, diarrhea, constipation, bronchitis, flu-like symptoms, and infection.

Please see the full Prescribing Information, including Medication Guide, for additional information about DEPAKOTE. Talk to your healthcare provider if you have questions.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit Abbvie.com/myAbbVieAssist to learn more.

REFERENCES

  1. Data on File, AbbVie Inc. IQVIA/LAAD Dataset, September 2019.
  2. Depakote Delayed-Release Tablets [package insert]. North Chicago, IL: AbbVie Inc.
  3. Depakote ER [package insert]. North Chicago, IL: AbbVie Inc.
  4. Depakote Sprinkle Capsules [package insert]. North Chicago, IL: AbbVie Inc.

If you have any questions about AbbVie's Depakote.com website that have not been answered, click here. This website and the information contained herein is intended for use by US residents only, is provided for informational purposes only, and is not intended to replace a discussion with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider and consider the unique characteristics of each patient.

© 2023 AbbVie.   All rights reserved.   US-DPKT-230009  

WHAT IS DEPAKOTE USED FOR?2-4

DEPAKOTE comes in different dosage forms for oral use. DEPAKOTE® (divalproex sodium) delayed-release tablets and DEPAKOTE® ER (divalproex sodium) extended-release tablets are prescription medicines used:

  • alone or with other medicines to treat:
    • complex partial seizures in adults and children 10 years of age and older
    • simple and complex absence seizures
  • with other medications to treat
    • patients with multiple seizure types that include absence seizures

DEPAKOTE ER and DEPAKOTE are also used to prevent migraine headaches.

DEPAKOTE ER is also used to treat acute manic or mixed episodes associated with bipolar disorder with or without psychotic features.

DEPAKOTE is also used to treat manic episodes associated with bipolar disorder.

IMPORTANT SAFETY INFORMATION2-4

The most important information about DEPAKOTE is:

Do not stop taking DEPAKOTE without first talking to your healthcare provider. Stopping DEPAKOTE suddenly can cause serious problems. Stopping a seizure medicine suddenly in a patient who has epilepsy can cause seizures that will not stop (status epilepticus).

DEPAKOTE can cause serious side effects, including:

  • Serious liver damage that can cause death, especially in children younger than 2 years old and patients with mitochondrial disorders. The risk of getting this serious liver damage is more likely to happen within the first 6 months of treatment. In some cases, liver damage may continue even though the medicine is stopped. Your healthcare provider will do blood tests to check your liver before and during treatment with DEPAKOTE. Call your healthcare provider right away if you get any of the following symptoms: feeling very weak, tired, or uncomfortable (malaise); swelling of your face; not feeling hungry; nausea or vomiting that does not go away; diarrhea; pain on the right side of your stomach (abdomen); dark urine; yellowing of your skin or the whites of your eyes; or loss of seizure control in people with epilepsy.
  • DEPAKOTE may harm your unborn baby. If you take DEPAKOTE during pregnancy for any medical condition, your baby is at risk for serious birth defects that affect the brain and spinal cord (such as spina bifida or neural tube defects). These defects can begin in the first month, even before you know you are pregnant. Other birth defects that affect the structures of the heart, head, arms, legs, and the opening where the urine comes out (urethra) on the bottom of the penis can also happen. Decreased hearing or hearing loss can also happen. Birth defects may occur even in children born to women who are not taking any medicines and do not have other risk factors. Taking folic acid supplements before getting pregnant and during early pregnancy can lower the chance of having a baby with a neural tube defect. If you take DEPAKOTE during pregnancy for any medical condition, your child is at risk for having a lower IQ and may be at risk for developing autism or attention-deficit/hyperactivity disorder. There may be other medicines to treat your condition that have a lower chance of causing birth defects, decreased IQ, or other disorders in your child. Women who are pregnant must not take DEPAKOTE to prevent migraine headaches. All women of childbearing age (including girls from the start of puberty) should talk to their healthcare provider about using other possible treatments instead of DEPAKOTE. If the decision is made to use DEPAKOTE, you should use effective birth control (contraception). Tell your healthcare provider right away if you become pregnant while taking DEPAKOTE. You and your healthcare provider should decide if you will continue to take DEPAKOTE while you are pregnant. Pregnancy Registry: If you become pregnant while taking DEPAKOTE, talk to your healthcare provider about registering with the North American Antiepileptic Drug (NAAED) Pregnancy Registry. You can enroll in this registry by calling toll-free 1-888-233-2334 or by visiting the website, www.aedpregnancyregistry.org. The purpose of this registry is to collect information about the safety of antiepileptic drugs during pregnancy.
  • Swelling (inflammation) and bleeding (hemorrhaging) of your pancreas that can cause death. Call your healthcare provider right away if you have any of these symptoms: severe stomach pain that you may also feel in your back, nausea or vomiting that does not go away, or not feeling hungry.
  • Like other antiepileptic drugs, DEPAKOTE may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call a healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry you: thoughts about suicide or dying; attempts to commit suicide; new or worse depression; new or worse anxiety; feeling agitated or restless; panic attacks; trouble sleeping (insomnia); new or worse irritability; acting aggressive; being angry or violent; acting on dangerous impulses; an extreme increase in activity and talking (mania); or other unusual changes in behavior or mood. How can I watch for early symptoms of suicidal thoughts and actions? Pay attention to any changes, especially sudden changes in mood, behaviors, thoughts, or feelings. Keep all follow-up visits with your healthcare provider as scheduled. Call your healthcare provider between visits as needed, especially if you are worried about symptoms.